Prakiraan wutah bathi resik saben saham kanggo taun ngarep Iovance Biotherapeutics, Inc. (IOVA)

Simbol lan logo merek Iovance (IOVA)

Iovance Biotherapeutics (IOVA) is attracting top specialists thanks to its first FDA-approved product and extensive career advancement opportunities. The forward earnings per share growth forecast demonstrates the issuer's resilience, with the metric standing at 75.00. The asset is shielded from macroeconomic shocks by stable demand for biotechnology, while growth scales through the creation of joint infrastructure with leading oncology centers.

IOVA - Prakiraan wutah bathi kanggo taun ngarep Iovance ing rentang 04.07.2022 - 16.11.2026

Rincian metrik lan analitis perusahaan Iovance (IOVA)

- rega lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:Iovance
Barang utama Iovance Biotherapeutics Inc

An analysis of the forward-looking EPS growth vector for Iovance Biotherapeutics (IOVA) reflects the consensus earnings forecast, where market expectations for business scaling clash with pragmatic calculations of future cash flows. This metric is sensitive to operational risks associated with CMO outsourcing and cellular material logistics, as any disruptions in the external contractor chain directly adjust the company's final profitability assessment.

Pesaing langsung

Prakiraan wutah bathi resik saben saham kanggo taun ngarep immunitybio.com|Prakiraan wutah bathi saben saham kanggo taun ngarep immunocore.com (IMCR)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Janux Therapeutics Inc (JANX)|Prakiraan wutah bathi saben saham kanggo taun ngarep Arcus Bio RCUS|Zymeworks Inc - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics Corp TNGX|IMTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|XNCR (xencor.com) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Compass Therapeutics Corp (CMPX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Replimune Corp (REPL)|Prakiraan wutah bathi saben saham kanggo taun ngarep LYEL|IPHA - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep PYXS (Pyxis Oncology, Inc.)|Proyeksi tambahing bathi saben saham ing taun ngarep CGEN|Prakiraan wutah bathi kanggo taun ngarep IOBT (IO Biotech)|Dinamika bathi saben saham sing diarepake ing taun ngarep STRO|minktherapeutics.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Werewolf Therapeutics, Inc.|Immix (IMMX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|ALX Oncology Holdings - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cue Biopharma|Prakiraan wutah bathi kanggo taun ngarep pdsbiotech.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep sonnetbio.com (SONN)|MAIA: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Liminatus Pharma Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|LAVA Therapeutics N.V. (LVTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|NXTC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LPTX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Intensity Therapeutics (INTS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Prakiraan wutah bathi kanggo taun ngarep|Gritstone bio (GRTS) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep KA|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep NexImmune Inc|Prakiraan wutah bathi resik saben saham kanggo taun ngarep turnstonebio.com TSBX|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Vaccinex Inc (VCNX)|HARP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep